Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Therapeutic Advances in Psychopharmacology
|
April 28, 2022
Will psilocybin lose its magic in the clinical setting?
Caroline Hayes, Mourad Wahba, Stuart Watson
Bjpsych Open
|
December 10, 2024
Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience
Mourad Wahba, Caroline Hayes, Maartje Kletter, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 10, 2019
Authors' reply
Mourad Wahba, Soraia Sousa, Stuart Watson, et al.
Journal of Affective Disorders
|
March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
BMJ Open
|
March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol
Lumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Journal of Affective Disorders
|
December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders
|
October 11, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
The Lancet. Psychiatry
|
July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK
Michael Browning, Philip J Cowen, Ushma Galal, et al.
Journal of Affective Disorders
|
February 5, 2023
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
The New England Journal of Medicine
|
November 2, 2022
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Therapeutic Advances in Psychopharmacology
|
April 28, 2022
Will psilocybin lose its magic in the clinical setting?
Caroline Hayes, Mourad Wahba, Stuart Watson
Bjpsych Open
|
December 10, 2024
Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience
Mourad Wahba, Caroline Hayes, Maartje Kletter, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
August 10, 2019
Authors' reply
Mourad Wahba, Soraia Sousa, Stuart Watson, et al.
Journal of Affective Disorders
|
March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
BMJ Open
|
March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol
Lumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Journal of Affective Disorders
|
December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders
|
October 11, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
The Lancet. Psychiatry
|
July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK
Michael Browning, Philip J Cowen, Ushma Galal, et al.
Journal of Affective Disorders
|
February 5, 2023
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
The New England Journal of Medicine
|
November 2, 2022
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Page
of 1